Tenet Healthcare
246 hedge funds and large institutions have $2.27B invested in Tenet Healthcare in 2017 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 96 increasing their positions, 72 reducing their positions, and 47 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
33% more repeat investments, than reductions
Existing positions increased: 96 | Existing positions reduced: 72
13% more capital invested
Capital invested by funds: $2.01B → $2.27B (+$265M)
13% more call options, than puts
Call options by funds: $61.3M | Put options by funds: $54.3M
3.93% more ownership
Funds ownership: 112.85% → 116.78% (+3.9%)
2% less funds holding
Funds holding: 252 → 246 (-6)
13% less first-time investments, than exits
New positions opened: 41 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$69.8M |
| 2 |
BlackRock
New York
|
+$19.4M |
| 3 |
DKCM
Davidson Kempner Capital Management
New York
|
+$18.2M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$17.5M |
| 5 |
ACG
Anchorage Capital Group
New York
|
+$17.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$94.8M |
| 2 |
LCOV
London Company of Virginia
Richmond,
Virginia
|
-$36.3M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$32.4M |
| 4 |
Goldman Sachs
New York
|
-$27.9M |
| 5 |
KSCM
King Street Capital Management
New York
|
-$17.7M |
THC Hedge Fund Activity: Q2 2017 in Review
246 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in Tenet Healthcare (THC) for Q2 2017, worth a combined $2.27B — up 13% from $2.01B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of THC and 41 opened new positions — a net loss of 6 holders — while 72 trimmed existing stakes and 96 added.
The largest buyer was Camber Capital Management, opening a new position worth an estimated $69.8M. The largest seller was OrbiMed, exiting entirely with an estimated $94.8M sold.
- 246 institutional investors held Tenet Healthcare (THC) as of Q2 2017, down from 252 in Q1 2017.
- Funds reported $2.27B of Tenet Healthcare stock for Q2 2017, up 13% quarter-over-quarter.
- 41 funds opened new Tenet Healthcare positions in Q2 2017 and 47 closed out, a net change of -6 holders.
- The largest Tenet Healthcare buyer in Q2 2017 was Camber Capital Management, an estimated $69.8M added.
- The largest Tenet Healthcare seller in Q2 2017 was OrbiMed, an estimated $94.8M sold.
Based on aggregated 13F filings for Q2 2017.